1. Introduction {#sec1}
===============

The management of pelvic tumors is a challenge for orthopaedic oncologists. Since 1980, when Enneking and Dunham \[[@B1]\] described the first classification of pelvic resections, internal hemipelvectomy has gradually replaced hindquarter amputation due to the improvements of surgical techniques and chemotherapy. Because the anatomy of the pelvis is complex, extensive exposure is needed to identify and protect major neurovascular structures.

This surgery is characterized by long operative times and consequently high number of complications, as reported by several authors \[[@B2]--[@B10]\].

Various reconstructive techniques have been proposed, such as iliofemoral coaptation and ischiofemoral arthrodesis, with poor functional results. The use of saddle or custom-made prosthesis can improve hip function in major resections but is characterized by high number of complications.

The use of large pelvic allograft is the most common technique to restore acetabular defects, but this procedure may be associated with high rate of complications, such as infections, nonunions, and fractures.

We believe that the use of iliac stem prosthesis, alone or in association with pelvic allograft, for acetabular defects following resections for periacetabular tumors simplifies reconstructive techniques and consequently can reduce the complications.

This technique can be used in a wide variety of patients, including children and patients who have received chemotherapy.

Our purpose is to determine the functional results and the rate of major complications of this type of reconstructions.

2. Materials and Methods {#sec2}
========================

Between 1999 and 2012, 45 patients underwent pelvic resections for periacetabular bone tumors followed by reconstruction with stem cup prosthesis ([Figure 1](#fig1){ref-type="fig"}). In 33 cases, this implant was associated with massive bone allografts, the so-called composite iliac stem prosthesis (CISP): stem cup prosthesis combined with allograft. The minimum follow-up required to evaluate functional outcome was 2 years.

General data and oncological outcomes are recorded ([Table 1](#tab1){ref-type="table"}). Twenty-four men and 21 women were enrolled in the study. The average age was 47 years (range 17--79 yrs). The mean follow-up was 60 months (range 1--154 months). The most common diagnosis was CS (chondrosarcoma, 29 cases), followed by OS (osteosarcoma, 9 cases) and metastasis (3 cases).

The patients underwent staging exams according to Enneking\'s stage system \[[@B11]\]. The most common stage was IIB.

All patients received intravenous antibiotic therapy preoperatively and for 3 weeks after surgery. When the tumor was located in the periacetabular region, an ilioinguinal surgical approach was used with an anterolateral and ileofemoral extension in order to obtain a good view of the neurovascular structures and a good internal and external exposure of the pelvis and hip joint. When the tumor was located in the proximal femur, an extended ileo-femoral approach was performed.

We classified pelvic resections according to Enneking and Dunham\'s classification \[[@B1]\] ([Figure 2](#fig2){ref-type="fig"}).

We performed 13 extra-articular femoral resections, removing the entire hip en bloc, when the tumor was located in the proximal femur and involved the joint and 32 intra-articular acetabular resections when the tumor was located in the pelvis, all of them involving P2 area. The most common type of resection was P2-P3 (14 cases) followed by P2 (12 cases). The mean operative time was 5.9 hours (range 4--10 hours). Complications and functional outcome are reported ([Table 2](#tab2){ref-type="table"}).

Reconstructions were performed all with iliac stem prosthesis ([Figure 3](#fig3){ref-type="fig"}) and in 33 cases associated with massive nonirradiated pelvic allograft stored at −80°C and thawed in rifampin solution ([Figure 4](#fig4){ref-type="fig"}).

In partial P2 resection, if residual bone stock was sufficient to obtain a stable implant, only stem cup prosthesis was used.

In P2 or P2-P3 resections we used CISP: stem prosthesis cemented in the allograft and press-fit in the residual iliac host bone ([Figure 4](#fig4){ref-type="fig"}).

In P1-P2 resections, the stem cap prosthesis was completely cemented ([Figure 5](#fig5){ref-type="fig"}).

In cases of CISP is very important to obtain a good matching between graft and host bone. Moreover, to improve the donor-to-host bone contact, a transiliac screw is added (Figures [4](#fig4){ref-type="fig"} and [8](#fig8){ref-type="fig"}). Either screws or a cerclage wire can be used for osteosynthesis of the anterior pelvic arch ([Figure 4](#fig4){ref-type="fig"}). This technique does not include the use of reconstruction plates along the innominate line or compression plates across the iliac osteotomy line. Occasionally, in order to improve implant stability, an artificial ligament is fixed between the ileopubic branch and the intertrochanteric region of the femur.

Hemovac drains were removed at a mean of 4-5 days after surgery. Partial weight bearing was started at 6 months and total weight bearing was begun at 9--12 months. Hip cast was used for the first 3 months.

Patients had follow-ups with X-ray of the pelvis and CT of the chest every 3 months during the first 3 years, then every 6 months during the fourth and fifth year, and yearly thereafter. Radiographic evaluation was assessed by two authors (DD and MD), in order to evaluate signs of nonunion, resorption of the graft, failure, or migration of the prosthetic components. Union of the graft to the host bone was said to have occurred if there was no visible osteotomy line at the junction sites or if greater than or equal to 75% of cortical thickness was fused on follow-up radiographs, according to the ISOLS radiological implants evaluation system \[[@B12]\]. Margins were classified as intralesional, marginal, and wide. Margins were wide in 31 cases, marginal in 10 cases, and intralesional in 2 cases.

Functional evaluation was performed at the most recent follow-up examination and using MSTS score system \[[@B13]\].

Patients\' ([Figure 6](#fig6){ref-type="fig"}) and prosthesis survival ([Figure 7](#fig7){ref-type="fig"}) was determined using Kaplan-Meier analysis. The end point for prosthetic survival was amputation or prosthesis removal.

The study was approved by the Institutional Ethics Committee and patients were informed about the proposed surgical procedure and alternative procedures, and informed consent was obtained in each case.

2.1. Oncological Results {#sec2.1}
------------------------

Sixteen patients died of their disease, three were lost to follow-up, four are alive with disease, and twenty-two are alive with no evidence of disease.

Fifteen patients had local recurrence (33%): margins were wide only in 9 of them. Ten were CS. All of them were extracompartimental, stage IB, or IIB.

Six of them were treated with hindquarter amputation, three with chemotherapy and radiotherapy, three with excision of the local recurrence, and one with resection and reconstruction with saddle prosthesis. One refused hindquarter amputation; one was lost to follow-up. Sixteen patients had bone or lung metastasis.

2.2. Complications and Functional Results {#sec2.2}
-----------------------------------------

The probability to have the prosthesis still in place was 60% at medium follow-up of 5 years ([Figure 7](#fig7){ref-type="fig"}).

We have had 6 infections (13%) that required in case 15 and 44 allograft and prosthesis removal (treated, resp., with cement spacer and new osteosynthesis with plate---case 15---and with modular prosthesis revision---case 44---), in 1 case only allograft removal (case 11---replaced with cement spacer), in 1 case surgical debridement (case 36), and in two cases hindquarter amputation (case 22 and 26). Three of them were patients who underwent chemotherapy for osteosarcoma.

Case 11 was a IIB OS that received chemotherapy and extrarticular femoral resection (H1-H2-P2) and reconstruction with allograft prosthetic composite (APC, i.e., femoral revision stem and femoral allograft). At last follow-up (99 months) he has no evidence of disease and poor function. Case 15 was a wide resection (P1-P2-P3) for a central CHS staged IB. A composite reconstruction was performed, but he developed lung metastasis and at last follow-up (75 months) he is alive with disease. Case 22 was a central CHS staged IB and treated with P2 resection and reconstruction with CISP. At last follow-up (112 months) she has no evidence of disease. Case 26 was a central CHS staged IB and treated with P2-P3 resection and reconstruction with CISP. She was lost to follow-up at 5 months. Case 36 was a IIB angiosarcoma who underwent P2-P3 resection and reconstruction with CISP. She was lost to follow-up at 38 months. Case 44 was a IIB OS that underwent P1-P2-P3 resection and reconstruction with CISP. At last follow-up she has a poor function.

We have had 2 aseptic loosenings (case 1 and 9), due, respectively, to allograft fracture during operation and wrong positioning of the stem cup prosthesis.

Case 1 was a P2 resection and was treated with revision of the implant (allograft and prosthesis). At last follow up (144 months) he has no evidence of disease and good function.

Case 9 was a P2 resection reconstructed only with stem cup prosthesis and underwent revision of the prosthesis. At 127 months from surgery she has no evidence of disease and fair function.

We report 2 cases of hip dislocation (case 12 and 27) both treated with revision surgery using longer head prosthesis and an artificial ligament between iliopubic branch and intertrochanteric area of the femur. Case 12 was a P2 resection and it has no evidence of disease at last follow-up (84 months) and has an excellent function. Case 27 was a radio-induced OS treated with P2-P3 resection and CSIP. She developed local recurrence, but she refused amputation.

Among minor complications, we report 2 cases of sciatic popliteal nerve palsy, partially recuperated, 2 cases of delay healing of wound surgery, 3 vein thrombosis, and 1 intolerance to sacroiliac screw which was removed.

Iliac sovracetabular osteotomy was fused in all cases at 10 months from surgery, while we report a frequent nonunion of anterior pelvic ring that has not affected implant stability ([Figure 8](#fig8){ref-type="fig"}).

Three of the patients evaluated with long follow-up had a resorption at the prosthesis-host bone interface, with a migration of the implant \<20 mm in 2 of them. Anyone underwent revision surgery.

Functional results were good or excellent in 25 of 31 patients with long-term follow-up (77%). Sixteen of them were partial P2 resections or P2-P3 resections reconstructed only with iliac stem prosthesis.

3. Discussion {#sec3}
=============

Surgical management of periacetabular tumors is a challenge for orthopaedic surgeons because of the complex anatomy of the pelvis and because there are important anatomical structures to preserve. Pelvic continuity and durable hip function are very difficult to achieve.

Several reconstructive options have been described to restore pelvic ring continuity, such as saddle prosthesis, custom-made prosthesis, and the use of allografts, alone or in association with prosthesis (composite reconstruction).

Saddle prosthesis was first described by Nieder in 1979 to fill wide acetabular defects in revision hip surgery. Then, they were used to reconstruct pelvic anatomy following resections for periacetabular tumors. But several studies \[[@B5], [@B8], [@B14], [@B15]\] evaluated this type of reconstruction reporting all limitations, including inacceptable functional results and high rate of complications, so their use is reserved to salvage surgery.

One of the first studies dealing with custom-made prosthesis was performed by Abudu et al. \[[@B16]\] in 1997. They analyzed the results of periacetabular resections performed on 35 patients for primary malignant tumors of the pelvis. According to them, the most important advantage of this technique was the possibility of a personalized reconstruction, which means to make the prosthesis preoperatively. They reported good functional results but high number of complications, above all infections and dislocations (60%), that required revision surgery in 40% of cases.

Customized prosthesis is made based on preoperative imaging data, which may not reflect the situation after resection if tumor-related or mechanical problems are discovered at surgery and require more extensive resection than planned. Conversely, pelvic allografts are larger than needed and are cut to size at the end of the resection step \[[@B3]\].

The most important advantages of composite reconstructions are the possibility to restore any bone defect by fitting the graft during surgery as well as osteointegration, revascularization, and partial replacement with host bone and the possibility to suture soft tissues to the graft, providing better results by developing a biologic union with the recipient bone. The most important disadvantage is the high infection rate, reported between 10 and 50% in the literature. Other disadvantages are fracture, non-union, the risk of viral disease transmission, and the necessity to have a musculoskeletal tissue bank.

Few records are reported in the literature about the use and results of pelvic allografts. In 1996, Ozaki et al. \[[@B2]\] presented the outcomes of 22 pelvic reconstructions with massime allografts for pelvic sarcomas, reporting high complication rates, such as 2 allograft fractures and 8 infections. Nine of them were removed. In 2001, Langlais et al. \[[@B3]\] reported the long-term results of hemipelvis reconstructions with allografts in 13 patients. Major complications were 1 infection and 2 dislocations. Functional results were good in 56% of patients.

In 2000, Yoshida et al. \[[@B17]\] described the outcomes of 19 patients who underwent reconstruction with pelvic allografts for periacetabular sarcomas. More frequent complications were 1 allograft fracture and 4 migrations of the bipolar prosthesis, which had led to total hip arthroplasty in 2 of them.

Delloye et al. \[[@B6]\] described the results of 18 reconstructions with allograft prosthetic composite in patients treated for sarcoma of the periacetabular region, reporting good results with rates of infection and functionality of 12.5% and 73%, respectively. This positive progression can be partly justified by the author by improving surgical techniques and imaging and the use of rifampin with which they thawed grafts. Best results (82% MSTS score) were obtained in children and adolescents. However, the reported rate of local recurrence was 29%, comparable to our percentage rate of 31%.

More recently, Donati et al. \[[@B7]\] analyzed the results of three different reconstructive techniques for periacetabular sarcomas. They divided patients in to three groups: the last of them was made up of 5 patients who underwent pelvic composite reconstruction with massive allografts with the same iliac stem prostheses described in this study. None of them developed mechanical complications or infections. This is the unique report about this type of reconstruction described in the literature.

Our purpose in this study was to determine implant survival and functional outcomes of these patients.

The most important limitation of our study is the presence of many uncontrolled variables, such as tumor grade and extent, the treatment, patient age, and reconstructive procedure, which have a confounding effect on dependent variables such as prosthesis survival. Moreover, there is the difficulty to compare our results with those of other authors because of differences in tumor type, extent of resection, and reconstruction techniques.

We observed 6 infections (13%), a rate similar to other series. All of them occurred in patients who underwent composite reconstruction with massive allografts and 3 of them in patients who underwent chemotherapy for OS. Other series, like for example, Ozaki\'s one \[[@B2]\], reported infection rate of 30%, which can be explained according the author to the long operative time, large blood loss, chemotherapy, and radiation therapy. In his series, infection was commoner in CS than in OS or ES, in large tumors than in small tumors, after a long operation time than after a short one. Indeed, the average tumor volume of CS was significantly larger than that of ES or OS, because chemotherapy reduces tumour volume before surgery: this may reduce operative times and consequently infection rate.

The use of rifampin solution to thaw the allografts is a factor influencing our low rate of infections, but other factors must be searched to explain it. According to us, the most important factor reducing infections is the low operative time (mean time 5.9 hours), due to an easy surgical technique that avoids the use of long plates and in selected cases the use of the stem cup prosthesis without allograft, such as when resection line can spare part of the acetabular roof and posterior wall.

We reported 2 aseptic loosening of the implant, due to wrong positioning of the prosthesis during surgery (that leads to an improper usury of polyethylene) and to an intraoperative fracture of the allograft.

Two dislocations are reported: both cases were not treated with artificial ligament. They were revised with longer head prosthesis and an artificial ligament between iliopubic branch and intertrocanteric area of the femur.

We had 15 local recurrences (30%). Among these patients 6 had inadequate margins and 8 were high-grade sarcomas. Ten were CS and all were extracompartimental, stage IB, or IIB. This high rate of local recurrence can be justified by different variables, such as the inadequate margins of resection in 6 of them (Donati et al. \[[@B4]\] have demonstrated yet that margins have a significant effect on the rate of local recurrence of CS); the huge volume of these tumors (indeed, tumors that usually occur in the pelvis are diagnosed late and therefore are of large size); the fact that chemotherapy has no effect on CS.

Our functional results are similar to those reported in the literature, between 56% and 75%.

4. Conclusions {#sec4}
==============

The use of a stemmed acetabular cup, alone or in association with a massive bone allograft, seems to be a valid alternative and a simple reconstruction technique. This type of reconstruction avoids complex osteosynthesis, such as contoured plates, therefore reducing significantly the operative time and early complication rates.

It allows having good results and low rate of complications, but it should be performed in selected cases and centres of reference.

No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this paper.
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###### 

General data.

  -------------------------------------------------------------------------------------------------------------------------------------------
  Patient   Gender   Age\      Stage   Diagnosis       Margins         Chemotherapy   Local\       Metastasis   Status   Patient follow-up\
                     (years)                                                          recurrence                         (months)
  --------- -------- --------- ------- --------------- --------------- -------------- ------------ ------------ -------- --------------------
  1         M        38        IA      Central CHS     Wide            No             No           No           NED      144

  2         W        48        IIB     CHS dediff      Wide            Yes            Yes          Yes          DOD      44

  3         M        40        IIA     Central CHS     Wide            No             No           No           NED      74

  4         W        37        III     Meta OS         Wide            Yes            No           Yes          DOD      24

  5         W        44        IIB     Central CHS     Wide            No             Yes          Yes          DOD      109

  6         W        71        IIB     CHS             Wide            No             No           Yes          DOD      7

  7         W        26        IIB     OS              Wide            Yes            No           No           DOD      60

  8         W        22        /       Mec failure     /               No             No           No           NED      154

  9         W        23        IB      Perif CHS       Marginal        No             No           No           NED      127

  10        W        68        IB      Central CHS     Marginal        No             Yes          No           DOD      80

  11        M        17        IIB     OS              Wide            Yes            No           No           NED      99

  12        M        48        IB      Central CHS     Wide            No             No           No           NED      84

  13        M        50        IB      Perif CHS       Intralesional   No             No           No           NED      103

  14        W        69        IB      Central CHS     Wide            No             No           No           NED      95

  15        M        37        IB      Central CHS     Marginal        No             No           Yes          AWD      75

  16        M        26        IIB     Meta ES         Intralesional   Yes            Yes          Yes          DOD      24

  17        M        70        IB      Central CHS     Wide            No             No           No           NED      94

  18        M        52        IB      CHS dediff      Wide            No             Yes          No           DOD      26

  19        M        27        III     OS              Wide            Yes            Yes          Yes          DOD      36

  20        M        32        IB      Central CHS     Wide            No             No           No           NED      104

  21        W        43        IB      OS              Wide            No             No           No           NED      77

  22        W        59        IB      Central CHS     Wide            No             Yes          No           NED      112

  23        M        27        /       Mec Failure     /               Yes            No           No           NED      101

  24        M        75        III     Meta K          Wide            No             No           No           LOST     10

  25        W        78        IIB     Central CHS     Wide            No             No           Yes          DOD      7

  26        W        58        IB      Central CHS     Wide            No             Yes          No           LOST     5

  27        W        79        IIB     OS Rx-induced   Marginal        No             Yes          No           AWD      41

  28        W        39        IB      Central CHS     Marginal        yes            Yes          Yes          AWD      44

  29        M        36        III     OS              Wide            yes            Yes          Yes          DOD      11

  30        M        60        IB      Central CHS     Wide            No             No           No           NED      70

  31        M        23        III     OS              Wide            Yes            No           Yes          DOD      24

  32        M        56        IB      Central CHS     Wide            no             No           Yes          DOD      1

  33        W        36        IIB     OS              Wide            Yes            Yes          No           DOD      14

  34        M        60        IB      Central CHS     Wide            No             No           No           NED      67

  35        M        65        IB      Central CHS     Wide            No             Yes          Yes          AWD      68

  36        W        63        IIB     Angiosarc.      Wide            yes            No           Yes          LOST     38

  37        M        18        IIB     ES              Marginal        Yes            No           No           NED      72

  38        W        45        IIB     CHS dediff      Wide            yes            Yes          Yes          DOD      4

  39        M        56        IB      Central CHS     Wide            No             No           No           NED      58

  40        W        57        IB      Central CHS     Wide            No             No           No           NED      68

  41        M        63        IA      Central CHS     Wide            No             No           No           NED      55

  42        M        51        IB      Central CHS     Marginal        No             No           No           NED      58

  43        M        66        IB      Central CHS     Marginal        No             No           No           NED      64

  44        W        33        IIB     OS              Wide            Yes            No           No           NED      58

  45        W        62        IB      Central CHS     Marginal        No             Yes          Yes          DOD      40
  -------------------------------------------------------------------------------------------------------------------------------------------

M: man; W: woman; CHS: chondrosarcoma; OS: osteosarcoma; ES: Ewing sarcoma; K: carcinoma; NED: no evidence of disease; DOD: dead of disease; AWD: alive with disease.

###### 

Type of resection, operative time, complications, and functional outcome of the patients. Artificial ligament was used in 21 cases.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Patient   Type of\         Surgical time\   Artificial\   Allograft   Infection   Joint\        Fracture   Nonunion   Mechanical\   Implant survival\   MSTS\
            resection        (hours)          ligament                              instability                         failure       (months)            score
  --------- ---------------- ---------------- ------------- ----------- ----------- ------------- ---------- ---------- ------------- ------------------- ---------------
  1         P2-P3            6                Yes           Yes         No          No            Yes        No         Yes           103                 Good

  2         P2-P3            6                Yes           Yes         No          No            No         No         No            29                  Fair

  3         P2-P1            7                Yes           Yes         No          No            No         No         No            74                  Good

  4         P1-P2            5                Yes           Yes         No          No            No         No         No            24                  Good

  5         P2               6,5              Yes           Yes         No          No            No         No         No            72                  Good

  6         H1-H2-P2         7,5              No            No          No          No            No         No         No            7                   Not evaluated

  7         H1-H2-P2         5                No            Yes         No          No            No         No         No            60                  Excellent

  8         H1-H2-P2         4                Yes           Yes         No          No            No         No         No            154                 Good

  9         P2-P3            6,5              No            No          No          No            No         No         Yes           35                  Fair

  10        P2-P3            /                No            No          No          No            No         No         No            26                  Fair

  11        H1-H2-P2         5                No            Yes         Yes         No            No         No         No            19                  Fair

  12        P2               5,5              No            Yes         No          Yes           No         No         No            55                  Excellent

  13        H1-P2            7                No            Yes         No          No            No         No         No            103                 Good

  14        H1-P2            6                No            Yes         No          No            No         No         No            95                  Excellent

  15        H1-P1-P2         7                Yes           Yes         Yes         No            No         No         No            8                   Not evaluated

  16        P-P3             8                Yes           No          No          No            No         No         No            21                  Not evaluated

  17        P2               5                No            No          No          No            No         No         No            94                  Excellent

  18        P2               7                Yes           Yes         No          No            No         No         No            27                  Good

  19        H1-H2-P2-P3      6                No            No          No          No            No         No         No            26                  Good

  20        P2-P3            8                Yes           Yes         No          No            No         No         No            104                 Excellent

  21        P2               4                No            Yes         No          No            No         No         No            77                  Excellent

  22        P2               5                No            Yes         Yes         No            No         No         No            40                  Fair

  23        H1-P2            5                No            No          No          No            No         No         No            101                 Good

  24        P2-P3            6                No            No          No          No            No         No         No            10                  Not evaluated

  25        P1-P2            5                Yes           Yes         No          No            No         No         No            7                   Not evaluated

  26        P2-P3            4,5              Yes           Yes         Yes         No            No         No         No            7                   Not evaluated

  27        P2-P3            6,5              No            No          No          Yes           No         No         No            41                  Excellent

  28        P1-P2-P3         6                Yes           Yes         No          No            No         No         No            44                  Good

  29        P2-P3            6                No            Yes         No          No            No         No         No            6                   Not evaluated

  30        P2-P3            6                Yes           Yes         No          No            No         No         No            69                  Excellent

  31        H1-H2-P1-P2      6                No            Yes         No          No            No         No         No            24                  Good

  32        H1-P2-P3         6                Yes           Yes         No          No            No         No         No            1                   Not evaluated

  33        P1-P2            5                Yes           Yes         No          No            No         No         No            12                  Not evaluated

  34        P1-P2-P3         10               Yes           Yes         No          No            No         No         No            67                  Good

  35        P2-P3            6                No            Yes         No          No            No         No         No            17                  Not evaluated

  36        P1-P2            6                No            Yes         Yes         No            No         No         No            38                  Poor

  37        P2               6                Yes           Yes         No          No            No         No         No            72                  Excellent

  38        H1-P2-P3         6                No            No          No          No            No         No         No            4                   Not evaluated

  39        P2               5                Yes           No          No          No            No         No         No            58                  Excellent

  40        P2-P3            5                No            No          No          No            No         No         No            68                  Poor

  41        P2               5                No            Yes         No          No            No         No         No            55                  Good

  42        P2-P3            6                Yes           Yes         No          No            No         No         No            58                  Good

  43        P2               5                Yes           Yes         No          No            No         No         No            64                  Excellent

  44        P1-P2-P3         6                No            Yes         Yes         No            No         No         No            15                  Not evaluated

  45        H1-H2-H3-P2-P3   6                /             Yes         No          No            No         No         No            10                  Not evaluated
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------
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